Ewing Sarcoma Breakpoint Region 1 (EWSR1) (Middle Region) Peptide
EWSR1
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits EWSR1
- EWSR1 (Ewing Sarcoma Breakpoint Region 1 (EWSR1))
- Protein Region
- Middle Region
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Séquence
- QSSFRQDHPS SMGVYGQESG GFSGPGENRS MSGPDNRGRG RGGFDRGGMS
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti- EWSR1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- EWSR1 (Ewing Sarcoma Breakpoint Region 1 (EWSR1))
- Synonymes
- EWS Peptide, bK984G1.4 Peptide, AU018891 Peptide, Ews Peptide, Ewsh Peptide, EWSR1 Peptide, fc04c01 Peptide, wu:fc04c01 Peptide, DKFZp459K1116 Peptide, ewsr1 Peptide, ewsr1.S Peptide, fb40b11 Peptide, fusl Peptide, wu:fb40b11 Peptide, wu:fb75g09 Peptide, zgc:55864 Peptide, EWS RNA binding protein 1 Peptide, Ewing sarcoma breakpoint region 1 Peptide, EWS RNA-binding protein 1 Peptide, EWS RNA-binding protein 1a Peptide, EWS RNA binding protein 1 L homeolog Peptide, EWS RNA-binding protein 1b Peptide, EWSR1 Peptide, Ewsr1 Peptide, ewsr1a Peptide, ewsr1 Peptide, ewsr1.L Peptide, ewsr1b Peptide
- Sujet
-
This gene encodes a multifunctional protein that is involved in various cellular processes, including gene expression, cell signaling, and RNA processing and transport. The protein includes an N-terminal transcriptional activation domain and a C-terminal RNA-binding domain. Chromosomal translocations between this gene and various genes encoding transcription factors result in the production of chimeric proteins that are involved in tumorigenesis. These chimeric proteins usually consist of the N-terminal transcriptional activation domain of this protein fused to the C-terminal DNA-binding domain of the transcription factor protein. Mutations in this gene, specifically a t(11,22)(q24,q12) translocation, are known to cause Ewing sarcoma as well as neuroectodermal and various other tumors. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 1 and 14.
Alias Symbols: EWS, EWS-FLI1, bK984G1.4
Protein Size: 354 - ID gène
- 2130
- NCBI Accession
- NM_001163285, NP_001156757
-
Vous êtes ici:
